Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Reversible hypoxic brain injury: the penumbra conundrum of Grinker.

Balan S, Gupta K, Balasundaram P, Jadon R.

BMJ Case Rep. 2019 Apr 23;12(4). pii: e228670. doi: 10.1136/bcr-2018-228670.

PMID:
31015246
2.

Thoracic involvement of diffuse lymphangiomatosis successfully treated with sildenafil.

Maurac A, Debray MP, Crestani B, Taillé C.

BMJ Case Rep. 2019 Apr 23;12(4). pii: e228523. doi: 10.1136/bcr-2018-228523.

PMID:
31015245
3.

Pyoderma gangrenosum-like lesion secondary to methylenetetrahydrofolate reductase mutation: an unusual presentation of a rare disease.

Turkowski Y, Razvi S, Ahmed AR.

BMJ Case Rep. 2019 Apr 23;12(4). pii: e228403. doi: 10.1136/bcr-2018-228403.

PMID:
31015243
4.

Lemierre's syndrome: a disguised threat.

Alves S, Stella L, Carvalho I, Moreira D.

BMJ Case Rep. 2019 Apr 23;12(4). pii: e228397. doi: 10.1136/bcr-2018-228397.

PMID:
31015242
5.

Cutaneous malakoplakia presenting as a groin swelling and graft failure.

Macdonald RA, Moyes C, Clancy M, Douglas P.

BMJ Case Rep. 2019 Apr 23;12(4). pii: e227460. doi: 10.1136/bcr-2018-227460.

PMID:
31015237
6.

Intraorbital aneurysm of the ophthalmic artery.

Garala P, Virdee J, Qureshi M, Gillow T.

BMJ Case Rep. 2019 Apr 23;12(4). pii: e227044. doi: 10.1136/bcr-2018-227044.

PMID:
31015236
7.

Comprehensive molecular imaging of malignant transformation of giant cell tumour of bone reveals diverse disease biology.

Kairemo K, Wang WL, Subbiah V.

BMJ Case Rep. 2019 Apr 23;12(4). pii: e218839. doi: 10.1136/bcr-2016-218839.

PMID:
31015231
8.

Targeting MEK in a Translational Model of Histiocytic Sarcoma.

Takada M, Hix JML, Corner S, Schall PZ, Kiupel M, Yuzbasiyan-Gurkan V.

Mol Cancer Ther. 2018 Nov;17(11):2439-2450. doi: 10.1158/1535-7163.MCT-17-1273. Epub 2018 Aug 22.

PMID:
30135215
9.

Clinical and Radiographic Gastrointestinal Abnormalities in McCune-Albright Syndrome.

Robinson C, Estrada A, Zaheer A, Singh VK, Wolfgang CL, Goggins MG, Hruban RH, Wood LD, Noë M, Montgomery EA, Guthrie LC, Lennon AM, Boyce AM, Collins MT.

J Clin Endocrinol Metab. 2018 Nov 1;103(11):4293-4303. doi: 10.1210/jc.2018-01022.

PMID:
30124968
10.

Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical Trial.

Danilenko M, Stamp E, Stocken DD, Husain A, Zangarini M, Cranston A, Stones R, Sinclair N, Hodgson K, Bowett SA, Roblin D, Traversa S, Plummer R, Veal G, Langtry JAA, Ashworth A, Burn J, Rajan N.

JAMA Dermatol. 2018 Aug 1;154(8):913-921. doi: 10.1001/jamadermatol.2018.1610.

11.

Ketohexokinase C blockade ameliorates fructose-induced metabolic dysfunction in fructose-sensitive mice.

Lanaspa MA, Andres-Hernando A, Orlicky DJ, Cicerchi C, Jang C, Li N, Milagres T, Kuwabara M, Wempe MF, Rabinowitz JD, Johnson RJ, Tolan DR.

J Clin Invest. 2018 Jun 1;128(6):2226-2238. doi: 10.1172/JCI94427. Epub 2018 Apr 23.

Supplemental Content

Loading ...
Support Center